Natural zeolites and white wines from Campania region (Southern Italy): a new contribution for solving some oenological problems

The purpose of this research is to provide a new mixture of Campanian zeolitized tuffs for solving two specific problems in the production of white wines: the protein and tartaric stability. In fact, a very frequent cause of turbidity and formation of organic deposits in white wines is the occurrence of thermolabile and thermostable proteins colloidal suspensions which precipitate in time, especially in summertime and during the storage and transport. Normally, to mitigate this risk wine producers use organic and inorganic stabilizers and clarifiers. The best known treatment, recognized also by the International Organisation of Vine and Wine (OIV) foresees the use of bentonite with a montmorillonite content not lower than 80%. The present paper aims at evaluating the use of two high zeolite grade Italian volcanoclastites such as the Neapolitan Yellow Tuff (NYT) and the Yellow Facies of the Campanian Ignimbrite (YFCI), in the treatment of three peculiar white wines of the Campanian region (Southern Italy): Falanghina, Fiano di Avellino and Greco di Tufo. Granulates were produced starting from tuff blocks as provided by quarries. Some grain size fractions have been prepared to investigate the zeolite content (phillipsite + chabazite + analcime) by X-ray diffraction (XRD). A 2-5 mm grain size fraction was chosen for NYT and a 5-10 mm for YFCI. Three Campanian monocultivar white wines were used for the test: the Falanghina 2006 vintage, the Fiano di Avellino DOCG 2007 vintage, and the Greco di Tufo DOCG 2008 vintage. 48 samples with mixture of the zeolitized tuffs, 1 sample with mixture of a synthetic zeolite A and 1 sample with mixture of a commercial sodium activated bentonite were prepared. ICP-OES analysis for the determination of ECEC, Ion Chromatography (IC) analyses for the determination of some major cations and Turbidimetric tests for the definition of the protein stabilization process before and after treatments were also carried out. It was evidenced that high zeolitized tuff/wine ratios enable the protein stabilization whereas a significant decrease of potassium ion after the treatment with a zeolite-rich powder improves the tartaric stability, a serious problem in all the wine productions. The results of these tests refer to a laboratory scale research. A transfer of the experiment to a pilot plant scale is in progress

Geochemical characteristics and mantle sources of the Oligo-Miocene primitive basalts from Sardinia: The role of subduction components.

During the Oligo-Miocene, the Island of Sardinia was covered by the products of voluminous magmatic activity, with a typical subduction-related signature. The mafic rocks of the Montresta (north) and Arcuentu (south) volcanic districts include primitive high MgO basalts whose trace element and Sr-, Nd- and Pb-isotope compositions constrain the nature and role of subduction-related components in the Tertiary Sardinian volcanism. The geochemical and isotopic data require an approximate degree of partial melting of 15% of a MORB-like depleted mantle prior to enrichment, and the input of two subduction components in the mantle wedge consisting of fluids from subducted oceanic crust (altered MORB) and fluids from subducted sediments. Ratios among trace elements which are variably compatible with fluid and melt phases (i.e. Th/Pb, Th/Nd and Sr/Nd) exclude the contribution of melts from the subducted slab. Models based on isotopic ratios indicate that the pre-subduction depleted mantle source of Sardinia magmas was enriched by 0.1-0.5% MORB fluid and less than 0.1% sediment fluid. The geochemical and isotopic compositions of the Montresta volcanic rocks are homogeneous, whereas those of the Arcuentu show quite heterogeneous characters, suggesting variations in mantle source over the long time-span (about 13 Ma) of volcanic activity in this district

Healthcare costs for treating relapsing multiple sclerosis and the risk of progression: a retrospective Italian cohort study from 2001 to 2015

Background Disease modifying treatments (DMTs) are the main responsible for direct medical costs in multiple sclerosis (MS). The current investigation aims at evaluating possible associations between healthcare costs for treating relapsing remitting MS (RRMS) and disease evolution. Methods The present cohort study retrospectively included 544 newly diagnosed RRMS patients, prospectively followed up for 10.1±3.3 years. Costs for DMT administration and management were calculated for each year of observation. Following clinical endpoints were recorded: time to first relapse, 1-point EDSS progression, reaching of EDSS 4.0, reaching of EDSS 6.0, and conversion to secondary progressive MS (SP). Covariates for statistical analyses were age, gender, disease duration and EDSS at diagnosis. Results At time varying Cox regression models, 10% increase in annual healthcare costs was associated with 1.1% reduction in 1-point EDSS progression (HR = 0.897; p = 0.018), with 0.7% reduction in reaching EDSS 6.0 (HR = 0.925; p = 0.030), and with 1.0% reduction in SP conversion (HR = 0.902; p = 0.006). Conclusion Higher healthcare costs for treating MS have been associated with a milder disease evolution after 10 years, with possible reduction of long-term non-medical direct and indirect costs

Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.

A large body of evidence suggests that, besides their cholesterol-lowering effect, statins exert anti-inflammatory action. Consequently, statins may have therapeutic potential in immune-mediated disorders such as multiple sclerosis. Our objectives were to determine safety, tolerability and efficacy of low-dose atorvastatin plus high-dose interferon beta-1a in multiple sclerosis patients responding poorly to interferon beta-1a alone. Relapsing–remitting multiple sclerosis patients, aged 18–50 years, with contrast-enhanced lesions or relapses while on therapy with interferon beta-1a 44 mg (three times weekly) for 12 months, were randomized to combination therapy (interferon+atorvastatin 20mg per day; group A) or interferon alone (group B) for 24 months. Patients underwent blood analysis and clinical assessment with the Expanded Disability Status Scale every 3 months, and brain gadolinium-enhanced magnetic resonance imaging at screening, and 12 and 24 months thereafter. Primary outcome measure was contrast-enhanced lesion number. Secondary outcome measures were number of relapses, EDSS variation and safety laboratory data. Forty-five patients were randomized to group A (n 1⁄4 21) or B (n 1⁄4 24). At 24 months, group A had significantly fewer contrast-enhanced lesions versus baseline (p 1⁄4 0.007) and significantly fewer relapses versus the two pre-randomization years (p < 0.001). At survival analysis, the risk for a 1-point EDSS increase was slightly higher in group B than in group A (p 1⁄4 0.053). Low-dose atorvastatin may be beneficial, as add-on therapy, in poor responders to high-dose interferon beta-1a alone

Temperature dependence of single particle excitations in a S=1 chain: exact diagonalization calculations compared to neutron scattering experiments

Exact diagonalization calculations of finite antiferromagnetic spin-1 Heisenberg chains at finite temperatures are presented and compared to a recent inelastic neutron scattering experiment for temperatures T up to 7.5 times the intrachain exchange constant J. The calculations show that the excitations at the antiferromagnetic point q=1 and at q=0.5 remain resonant up to at least T=2J, confirming the recent experimental observation of resonant high-temperature domain wall excitations. The predicted first and second moments are in good agreement with experiment, except at temperatures where three-dimensional spin correlations are most important. The ratio of the structure factors at q=1 and at q=0.5 is well predicted for the paramagnetic infinite-temperature limit. For T=2J, however, we found that the experimentally observed intensity is considerably less than predicted. This suggests that domain wall excitations on different chains interact up to temperatures of the order of the spin band width.Comment: 9 pages revtex, submitted to PR

Haldane gap in the quasi one-dimensional nonlinear σ\sigma-model

This work studies the appearance of a Haldane gap in quasi one-dimensional antiferromagnets in the long wavelength limit, via the nonlinear $\sigma$-model. The mapping from the three-dimensional, integer spin Heisenberg model to the nonlinear $\sigma$-model is explained, taking into account two antiferromagnetic couplings: one along the chain axis ($J$) and one along the perpendicular planes ($J_\bot$) of a cubic lattice. An implicit equation for the Haldane gap is derived, as a function of temperature and coupling ratio $J_\bot/J$. Solutions to these equations show the existence of a critical coupling ratio beyond which a gap exists only above a transition temperature $T_N$. The cut-off dependence of these results is discussed.Comment: 14 pages (RevTeX 3.0), 3 PostScript figures appended (printing instructions included

Field induced transition of the S=1 antiferromagnetic chain with anisotropy

The ground state magnetization process of the S=1 antiferromagnetic chain with the easy-axis single-ion anisotropy described by negative $D$ is investigated. It is numerically found that a phase transition between two different gapless phases occurs at an intermediate magnetic field between the starting and saturation points of the magnetization for $-1.49<D<-0.35$. The transition is similar to the spin flopping, but it is second-order and not accompanied with any significant anomalous behaviors in the magnetization curve. We also present the phase diagrams in the m-D and H-D planes which reveal a possible re-entrant transition.Comment: 6 pages, Revtex, with 6 eps figures, to appear in Phys. Rev. B (Sep. 1